Gabriella Miklóssy et al.
Protein engineering, design & selection : PEDS, 21(7), 453-461 (2008-05-16)
An intracellularly expressed defective human immunodeficiency virus type-1 (HIV-1) protease (PR) monomer could function as a dominant-negative inhibitor of the enzyme that requires dimerization for activity. Based on in silico studies, two mutant PRs harboring hydrophilic mutations, capable of forming